ArticleBMC infectious diseases2019

Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort.

Anne Laurain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.